Viewpoints: Hantavirus Cruise Ship Outbreak Is A Global Warning; Should Everyone Be On A GLP-1?

https://kffhealthnews.org/morning-breakout/viewpoints-hantavirus-cruise-ship-outbreak-is-a-global-warning-should-everyone-be-on-a-glp-1/

Longer Looks: Interesting Reads You Might Have Missed

Longer Looks: Interesting Reads You Might Have Missed Each week, KFF Health News finds longer stories for you to read. Today's selections are on veterans' healthcare, drug detox, longevity, Parkinson's disease, and more. https://kffhealthnews.org/morning-breakout/longer-looks-interesting-reads-you-might-have-missed-263/

Management Consultants For Nonprofit Hospitals Might Not Be Worth The Price: Study

Management Consultants For Nonprofit Hospitals Might Not Be Worth The Price: Study According to a study published on the JAMA Network, nonprofit hospitals are emulating their for-profit counterparts and outsourcing management services. The study's findings show no statistical evidence of management consultants' effectiveness. https://kffhealthnews.org/morning-breakout/not-ready-health-industry/

NC Abortion Clinic Closure Highlights Growing Strain On Providers

NC Abortion Clinic Closure Highlights Growing Strain On Providers The closure of A Woman's Choice clinic in Greensboro leaves 17 clinics in North Carolina, spread across nine counties, North Carolina Health News reports. Amber Gavin, the clinic's vice president of advocacy and operations, stated that the closure was the result of increased restrictions, financial strain, and a “hostile political environment." https://kffhealthnews.org/morning-breakout/maybe-top-3-states/

RFK Jr. Defends Decision To Roll Back Hepatitis B Vaccine For Infants

RFK Jr. Defends Decision To Roll Back Hepatitis B Vaccine For Infants Health and Human Services Secretary Robert F. Kennedy Jr. was challenged over his most controversial policy reversal during a Cleveland Summit he attended. Kennedy defended the policy change, arguing it was driven by concerns about inadequate safety testing. The vaccine has not been taken off the market or removed from insurance coverage, The (Cleveland) Plain Dealer reports. https://kffhealthnews.org/morning-breakout/vaccines/

What the Health? From KFF Health News: Abortion Pill Politics

https://kffhealthnews.org/podcast/what-the-health-445-abortion-pill-mifepristone-makary-may-7-2026/ What the Health? From KFF Health News: Abortion Pill Politics A federal court’s decision to restrict availability of the abortion pill mifepristone has launched abortion back into the national spotlight. It’s also raised new questions about the job security of FDA Commissioner Marty Makary. Sandhya Raman of Bloomberg Law, Shefali Luthra of The 19th, and Jessie Hellmann of CQ Roll Call join KFF Health News’ Julie Rovner to discuss these stories and more. Also, Rovner interviews KFF Health News’ Andrew Jones, who wrote the latest “Bill of the Month." ( 5/7 )

Medicare To Launch Pilot GLP-1 Drug Program For $50 A Month

Medicare To Launch Pilot GLP-1 Drug Program For $50 A Month FDA-approved GLP-1 medications, in both injectable and pill form, will be available with a $50 monthly co-pay to beneficiaries enrolled in Medicare Part D or a Medicare Advantage plan with drug coverage. The pilot program will start in July and run through 2027. https://kffhealthnews.org/morning-breakout/weight-loss-pharma/